CRSP stock is in free fall. I don't know why. I do know that they, along with Vertex, are going to make billions of dollars with Casgevy. As it stands, the total addressable market in the US and Europe is around $70B. Vertex is trying to up that number to $300B by eliminating some of the chemotherapy and such needed for treatment. There's more money to be made in other areas of the world, too. I believe they're splitting profit 60/40. Right now, CRSP has a market cap of $4.34B. I'm guessing by this time next year, they're going to be making A LOT of money from this one therapy. They do need to hit on some more of their pipeline for long term success. I'm feeling good about this one and will keep accumulating shares.